BackgroundCheck.run
Search For

Raymond Charles Bergan, 65Omaha, NE

Known as:
Raymond C Bergan Raymond L Bergan Raymomd C Bergan Ray Bergan Ray C Beerga Gail Bergan Ray N
Related to:
Michelle R Manso 60

Raymond Bergan Phones & Addresses

Omaha, NE   

Portland, OR   

Springville, NY   

1454 Glenlake Ave, Chicago, IL 60660    773-4651589   

1873 Fremont St, Chicago, IL 60614    773-6401680   

Rockville, MD   

Bethesda, MD   

1873 N Fremont St #1, Chicago, IL 60614    773-2514969   

Work

Company: Williams & Connolly Address: 725 Twelfth Street N West, Washington, DC 20005 Specialities: Litigation - 34% • Antitrust / Trade Law - 33% • Commercial - 33%

Education

Degree: LL.B - Bachelor of Laws School / High School: Georgetown University Law Center

Ranks

Licence: Dist. of Columbia - Active Date: 1954
Get Report
Control this profile

Mentions for Raymond Charles Bergan

Career records & work history

Lawyers & Attorneys

Raymond Bergan Photo 1

Raymond W Bergan, Washington DC - Lawyer

Address:
Williams & Connolly
725 Twelfth Street N West, Washington, DC 20005
Licenses:
Dist. of Columbia - Active 1954
Education:
Georgetown University Law CenterDegree LL.B - Bachelor of LawsGraduated 1954
Holy Cross CollegeDegree BS - Bachelor of ScienceGraduated 1952
Specialties:
Litigation - 34%
Antitrust / Trade Law - 33%
Commercial - 33%

Medicine Doctors

Raymond C. Bergan

Specialties:
Medical Oncology
Education:
Medical School
SUNY Upstate Medical University
Graduated: 1987
Procedures:
Bone Marrow Biopsy
Conditions:
Leukemia, Prostate Cancer, Anemia, Anxiety Phobic Disorders, Arterial Thromboembolic Disease, Atherosclerosis, Bladder Cancer, Chronic Renal Disease, Cirrhosis, Diabetes Mellitus (DM), Gastric Cancer, Heart Failure, Hypertension (HTN), Infectious Liver Disease, Iron Deficiency Anemia, Kidney Cancer, Liver Cancer, Lung Cancer, Malignant Neoplasm of Colon, Malignant Neoplasm of Female Breast, Multiple Myeloma, Non-Hodgkin's Lymphoma, Obstructive Sleep Apnea, Osteoporosis, Overweight and Obesity, Pancreatic Cancer, Pneumonia, Pulmonary Embolism, Rectal, Abdomen, Small Intestines, or Colon Cancer, Skin Cancer, Testicular Cancer, Urinary Incontinence
Description:
Dr. Bergan graduated from the SUNY Upstate Medical University in 1987. He works in Chicago, IL and 1 other location and specializes in Medical Oncology. Dr. Bergan is affiliated with Jesse Brown VA Medical Center, Oregon Health Science University Hospital and VA Medical Center Portland.
Raymond Bergan Photo 2

Raymond Bergan, Chicago IL

Specialties:
Internal Medicine
Medical Oncology
Hematology & Oncology
Work:
Jesse Brown Va Medical Center
820 S Damen Ave, Chicago, IL 60612312-695-7950
675 N Saint Clair St, Chicago, IL 60611
Education:
Upstate Medical University Physical Medicine and Rehabilitation (1987)

Raymond Bergan resumes & CV records

Resumes

Raymond Bergan Photo 12

External Advisory Committee, Nci Early Phase Cancer Prevention Program

Location:
3181 southwest Sam Jackson Park Rd, Portland, OR 97239
Industry:
Higher Education
Work:
National Cancer Institute (Nci)
External Advisory Committee, Nci Early Phase Cancer Prevention Program Ecog-Acrin Cancer Clinical Trials Cooperative Group
Chair, Prevention Committee Knight Cancer Institute
Co-Leader, Translational Oncology Program Northwestern University Sep 1998 - Jan 2015
Professor of Medicine Oregon Health & Science University Knight Cancer Institute Sep 1998 - Jan 2015
Head, Division of Hematology and Oncology; Associate Director, Knight Cancer Center Third Coast Therapeutics Sep 1998 - Jan 2015
Member, Board of Directors; Chief Medical Officer; Co-Founder; Co-Owner National Institutes of Health Jul 1993 - Aug 1998
Investigator
Education:
Harvard T.h. Chan School of Public Health 2015 - 2015
Upstate Medical Center, Syracuse 1987 - 1990
State University of New York Upstate Medical University 1983 - 1987
Doctor of Medicine, Doctorates, Medicine University at Buffalo 1979 - 1983
Bachelors, Biochemistry
Skills:
Cancer, Clinical Research, Molecular Biology, Cell, Research, Life Sciences, Clinical Trials, Oncology, Biochemistry, Drug Discovery, Academic Research, Science, Medicine, Public Health, Biotechnology, Healthcare, Academic Administration
Languages:
English
Mandarin
Raymond Bergan Photo 13

Telecom Mgr. At Fairmont Turnberry Isle Resort And Club

Raymond Bergan Photo 14

Account Mgr. At Black Box

Publications & IP owners

Us Patents

Inhibition And Treatment Of Prostate Cancer Metastasis

US Patent:
8481760, Jul 9, 2013
Filed:
Oct 13, 2009
Appl. No.:
12/578137
Inventors:
Raymond C. Bergan - Chicago IL, US
Karl A. Scheidt - Evanston IL, US
Assignee:
Northwestern University - Evanston IL
International Classification:
C07D 311/00
A61K 31/35
US Classification:
549403, 514456
Abstract:
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.

Inhibition And Treatment Of Prostate Cancer Metastasis

US Patent:
2009012, May 14, 2009
Filed:
Oct 13, 2008
Appl. No.:
12/250351
Inventors:
Raymond C. Bergan - Chicago IL, US
Karl A. Scheidt - Evanston IL, US
Assignee:
NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:
A61K 31/7105
C12N 5/08
G01N 33/53
A61K 31/352
A61P 35/00
US Classification:
514 44, 435375, 435 71, 514456
Abstract:
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.

Inhibition And Treatment Of Prostate Cancer Metastasis

US Patent:
2012028, Nov 8, 2012
Filed:
Jul 23, 2012
Appl. No.:
13/555537
Inventors:
Raymond C. Bergan - Chicago IL, US
Karl A. Scheidt - Evanston IL, US
Assignee:
NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:
A61K 31/352
A61K 31/7105
C12N 5/09
C12N 9/99
A61P 35/04
C07D 311/36
G01N 33/573
C12Q 1/68
G01N 21/00
A61K 31/7088
C12Q 1/48
US Classification:
514 44 A, 514456, 435375, 435184, 435 15, 549403, 435 74, 435 613, 435 612, 435 61
Abstract:
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.

Inhibition Of Protein Kinase Activity By Aptameric Action Of Oligonucleotides

US Patent:
5998596, Dec 7, 1999
Filed:
Apr 4, 1995
Appl. No.:
8/416214
Inventors:
Raymond Bergan - Rockville MD
Len Neckers - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
C07H 1900
C07H 2102
C07H 2104
C12N 1500
US Classification:
536 221
Abstract:
The present invention are oligonucleotides that specifically bind to and directly inhibit the biological function of target molecules such as proteins, peptides or derivatives. The direct or aptameric interaction of oligonucleotides of the present invention with proteins, peptides and derivatives represents a non-antisense mediated effect. The oligonucleotides have been shown to bind to isolated target molecules and to inhibit biological function of the target molecule within cells. In particular, the oligonucleotides have been shown to directly inhibit the kinase activity of protein-tyrosine kinase. The oligonucleotides of the present invention have significant beneficial effects against a chronic myelogenous leukemia derived cell line as demonstrated using cellular phosphotyrosine content as well as cellular growth in soft agar.

Possible Relatives

Daniel E Bergan  Eric Bergan  Erin E Bergan  Greta B Bergan  Jeffrey Bergan  Katherine E Bergan  Kathryn V Bergan  Raymond W Johnson  Raymond D Johnston  Raymond V Standre 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.